Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-20-045095
Date:2020-08-03
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
Original Submission Date:

Reporting Person:

ALTSHULER DAVID
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE BOSTON, MA 02210

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-08-03 M 2,330 a $86.52 31,232 direct
COMMON STOCK 2020-08-03 S 458 d $276.84 30,774 direct
COMMON STOCK 2020-08-03 S 1,167 d $278.14 29,607 direct
COMMON STOCK 2020-08-03 S 605 d $279.19 29,002 direct
COMMON STOCK 2020-08-03 S 100 d $279.98 28,902 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 86.52 2020-08-03 deemed execution date M 2,330 (d) 2027-02-02 common stock 2,330 $86.52 4,660 direct
Footnotes
IDfootnote
f1 transaction made pursuant to dr. altshuler's company approved trading plan under rule 10b5-1.
f2 open market sales reported on this line occurred at a weighted average price of $276.84 (range $276.62 to $277.20).
f3 dr. altshuler undertakes to provide (upon request by the sec staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
f4 open market sales reported on this line occurred at a weighted average price of $278.14 (range $277.79 to $278.65).
f5 open market sales reported on this line occurred at a weighted average price of $279.19 (range $278.86 to $279.62).
f6 the option vests in 16 quarterly installments from 02/03/2017.
WhaleWisdom Logo

Elevate your investments